Synergistic anticancer activity of cannabinoids and beta caryophyllene in xenograft mouse model of triple negative breast cancer

被引:0
作者
Aare, Mounika
Khan, Islauddin
Nathani, Aakash
Boirie, Breana
Bagde, Arvind
Singh, Mandip
机构
关键词
D O I
10.1158/1538-7445.AM2024-4566
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4566
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Utilizing a decellularized patient-derived xenograft tumor model for the evaluation of triple negative breast cancer
    Wright, Maryl
    Matossian, Margarite
    King, Connor
    Nguyen, Khoa
    Elliott, Steven
    Alzoubi, Madlin
    Martin, Elizabeth
    Collins-Burow, Bridgette
    Burow, Matthew
    CANCER RESEARCH, 2020, 80 (04)
  • [32] Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
    Matossian, Margarite D.
    Burks, Hope E.
    Elliott, Steven
    Hoang, Van T.
    Bowles, Annie C.
    Sabol, Rachel A.
    Wahba, Bahia
    Anbalagan, Muralidharan
    Rowan, Brian
    Abazeed, Mohamed E.
    Bunnell, Bruce A.
    Moroz, Krzysztof
    Miele, Lucio
    Rhodes, Lyndsay V.
    Jones, Steven D.
    Martin, Elizabeth C.
    Collins-Burow, Bridgette M.
    Burow, Matthew E.
    BMC CANCER, 2019, 19 (1)
  • [33] Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
    Margarite D. Matossian
    Hope E. Burks
    Steven Elliott
    Van T. Hoang
    Annie C. Bowles
    Rachel A. Sabol
    Bahia Wahba
    Muralidharan Anbalagan
    Brian Rowan
    Mohamed E. Abazeed
    Bruce A. Bunnell
    Krzysztof Moroz
    Lucio Miele
    Lyndsay V. Rhodes
    Steven D. Jones
    Elizabeth C. Martin
    Bridgette M. Collins-Burow
    Matthew E. Burow
    BMC Cancer, 19
  • [34] Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells
    Burnett, Joseph P.
    Lim, Gi
    Li, Yanyan
    Shah, Ronak B.
    Lim, Rebekah
    Paholak, Hayley J.
    McDermott, Sean P.
    Sun, Lichao
    Tsume, Yasuhiro
    Bai, Shuhua
    Wicha, Max S.
    Sun, Duxin
    Zhang, Tao
    CANCER LETTERS, 2017, 394 : 52 - 64
  • [35] iMN041 is an immunotherapeutic and an effective treatment in mouse xenograft models of pancreatic cancer, renal cancer and triple negative breast cancer
    Richard Daifuku
    Yu Zhang
    Jingjing Wang
    Qingyang Gu
    Translational Medicine Communications, 9 (1)
  • [36] A Recombinant Adenovirus Vector Containing the synNotch Receptor Gene Inhibits Tumor Growth of Triple-Negative Breast Cancer in a Mouse Xenograft Model
    Ruhan, A.
    Kitagawa, Koichi
    Kunimura, Naoto
    Fujisawa, Masato
    Shirakawa, Toshiro
    MOLECULAR THERAPY, 2023, 31 (04) : 774 - 774
  • [37] CTCs-derived xenograft development in a triple negative breast cancer case
    Pereira-Veiga, Tais
    Abreu, Manuel
    Robledo, Diego
    Matias-Guiu, Xavier
    Santacana, Maria
    Sanchez, Laura
    Cueva, Juan
    Palacios, Patricia
    Abdulkader, Ihab
    Lopez-Lopez, Rafael
    Muinelo-Romay, Laura
    Costa, Clotilde
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (09) : 2254 - 2265
  • [38] Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer
    Johnstone, Cameron N.
    Pattison, Andrew D.
    Gorringe, Kylie L.
    Harrison, Paul F.
    Powell, David R.
    Lock, Peter
    Baloyan, David
    Ernst, Matthias
    Stewart, Alastair G.
    Beilharz, Traude H.
    Anderson, Robin L.
    DISEASE MODELS & MECHANISMS, 2018, 11 (05)
  • [39] Application of triple negative breast cancer patient-derived organoid and xenograft model for drug screening
    Ryu, Seungyeon
    Kim, Hoe Suk
    Kim, Jung Eun
    Yoon, So-Hyun
    Lee, Sangeun
    Baek, Moonjou
    Lee, Han-Byoel
    Lee, Dong Woo
    Ku, Bosung
    Han, Wonshik
    CANCER RESEARCH, 2022, 82 (12)
  • [40] A Recombinant Adenovirus Vector Containing the synNotch Receptor Gene Inhibits Tumor Growth in a Mouse Xenograft Model of Triple-Negative Breast Cancer
    Tominaga, Shoko
    Kunimura, Naoto
    Kitagawa, Koichi
    Doi, Hazuki
    Ruhan, A.
    Fujisawa, Masato
    Shirakawa, Toshiro
    MOLECULAR THERAPY, 2021, 29 (04) : 324 - 324